2022
Opioid tapering support using a web-based app: Development and protocol for a pilot randomized controlled trial
Edmond SN, Wesolowicz DM, Moore BA, Ibarra J, Chhabra M, Fraenkel L, Becker WC. Opioid tapering support using a web-based app: Development and protocol for a pilot randomized controlled trial. Contemporary Clinical Trials 2022, 119: 106857. PMID: 35863697, DOI: 10.1016/j.cct.2022.106857.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidHumansInternetMobile ApplicationsPainPilot ProjectsQuality of LifeRandomized Controlled Trials as TopicConceptsPilot trialLong-term opioid therapyPatient-reported outcomesRandomized-controlled trialQuality of lifeSelf-management skillsOpioid taperOpioid therapyOpioid usePrimary outcomePrimary careTwo-armLimited efficacyInteractive web-based programControl groupIntervention MappingWeb-based programPatientsPeer specialistsTrialsPotential harmSummit programWeb-based appCareOutcomes
2016
Interim Buprenorphine vs. Waiting List for Opioid Dependence
Sigmon SC, Ochalek TA, Meyer AC, Hruska B, Heil SH, Badger GJ, Rose G, Brooklyn JR, Schwartz RP, Moore BA, Higgins ST. Interim Buprenorphine vs. Waiting List for Opioid Dependence. New England Journal Of Medicine 2016, 375: 2504-2505. PMID: 28002704, PMCID: PMC5373028, DOI: 10.1056/nejmc1610047.Peer-Reviewed Original ResearchMeSH KeywordsBuprenorphineHumansNarcotic AntagonistsOpioid-Related DisordersPilot ProjectsWaiting Lists
2015
Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility
Sigmon SC, Meyer A, Hruska B, Ochalek T, Rose G, Badger GJ, Brooklyn JR, Heil SH, Higgins ST, Moore BA, Schwartz RP. Bridging waitlist delays with interim buprenorphine treatment: Initial feasibility. Addictive Behaviors 2015, 51: 136-142. PMID: 26256469, PMCID: PMC4558243, DOI: 10.1016/j.addbeh.2015.07.030.Peer-Reviewed Original ResearchConceptsInterim buprenorphine treatmentBuprenorphine treatmentWeek 2ASI drug composite scoresIllicit opioid abstinenceOpioid-dependent adultsIllicit opioid useDrug composite scoresPercent of participantsInitial feasibilityPast-month drug useWaitlist delaysOpioid cravingOpioid withdrawalBuprenorphine administrationOpioid useSecondary outcomesBuprenorphine inductionDaily medicationOpioid abstinencePrimary outcomeIllicit opioidsOpioid dependenceWeek 12Agonist maintenance
2014
A pilot trial of a videogame-based exercise program for methadone maintained patients
Cutter CJ, Schottenfeld RS, Moore BA, Ball SA, Beitel M, Savant JD, Stults-Kolehmainen MA, Doucette C, Barry DT. A pilot trial of a videogame-based exercise program for methadone maintained patients. Journal Of Substance Use And Addiction Treatment 2014, 47: 299-305. PMID: 25012555, PMCID: PMC4487635, DOI: 10.1016/j.jsat.2014.05.007.Peer-Reviewed Original ResearchConceptsExercise interventionSubstance useSubstance use disorder treatmentMethadone-maintained patientsStudy completion ratesPhysical activity levelsGreater physical activityWii Fit PlusUse disorder treatmentExercise programSedentary controlsPilot trialPhysical activityDisorder treatmentActive game playPilot studyActivity levelsInterventionPatientsCompletion ratesHigh satisfactionFurther investigationTrialsPsychological wellnessParticipants
2013
The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance
Moore BA, Fazzino T, Barry DT, Fiellin DA, Cutter CJ, Schottenfeld RS, Ball SA. The Recovery Line: A pilot trial of automated, telephone-based treatment for continued drug use in methadone maintenance. Journal Of Substance Use And Addiction Treatment 2013, 45: 63-69. PMID: 23375114, PMCID: PMC3642223, DOI: 10.1016/j.jsat.2012.12.011.Peer-Reviewed Original ResearchMeSH KeywordsAdaptation, PsychologicalAdultAutomationCocaine-Related DisordersFeasibility StudiesFemaleHumansMaleMethadoneMiddle AgedOpiate Substitution TreatmentOpioid-Related DisordersPatient Acceptance of Health CarePatient SatisfactionPilot ProjectsSubstance Abuse DetectionTelephoneTherapy, Computer-AssistedConceptsMethadone maintenanceLarge clinical trialsTelephone-based treatmentCurrent pilot studyPatient satisfactionClinical trialsPatient utilizationComputer-based treatmentPilot trialInitial efficacyInteractive voice response systemDrug usePatientsScreen outcomesVoice response systemPilot studyIllicit drugsTreatmentDaily useTrialsEfficacyOpioidsAbstinenceRecovery lineCocaine
2012
Counseling and Directly Observed Medication for Primary Care Buprenorphine Maintenance
Moore BA, Barry DT, Sullivan LE, O'Connor PG, Cutter CJ, Schottenfeld RS, Fiellin DA. Counseling and Directly Observed Medication for Primary Care Buprenorphine Maintenance. Journal Of Addiction Medicine 2012, 6: 205-211. PMID: 22614936, PMCID: PMC3419276, DOI: 10.1097/adm.0b013e3182596492.Peer-Reviewed Original ResearchConceptsCognitive behavioral therapyPhysician managementObserved medicationBaseline characteristicsCBT sessionsOpioid-negative urinesIndividual CBT sessionsBuprenorphine maintenanceOpioid useMedication adherencePatient satisfactionPrimary careImproved outcomesTreatment outcomesSession attendanceNegative urineTreatment groupsGreater abstinenceCounseling intensityDrug useTherapist availabilityMedicationsBuprenorphinePatientsIndependent effects
2006
A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care
Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA. A Trial of Integrated Buprenorphine/Naloxone and HIV Clinical Care. Clinical Infectious Diseases 2006, 43: s184-s190. PMID: 17109305, DOI: 10.1086/508182.Peer-Reviewed Original ResearchMeSH KeywordsAdministration, SublingualAdultAntiretroviral Therapy, Highly ActiveBuprenorphineDose-Response Relationship, DrugDrug Administration ScheduleFemaleFollow-Up StudiesHIV InfectionsHumansMaleMiddle AgedNaloxoneNarcotic AntagonistsOpioid-Related DisordersPilot ProjectsProbabilityReference ValuesRisk FactorsTreatment OutcomeConceptsHIV clinical careHIV-1 RNA copies/mLBuprenorphine/naloxone treatmentRNA copies/mLCopies/mLOpioid dependenceClinical careOpioid useNaloxone treatmentPhysician managementTreatment retentionHIV type 1 RNA levelsHIV-1 RNA levelsDose of buprenorphinePartial opioid agonistRNA levelsCD4 lymphocyte countBuprenorphine/naloxoneOpioid-dependent patientsUrine toxicology testsWeeks of treatmentHuman immunodeficiency virusUrine test resultsBetter treatment retentionUntreated opioid dependence